全球注册研究中接受肾脏替代治疗患儿的功能结局
出院FSS与合并症是6个月FSS的显著预测因素。
要点
- 存活患儿出院后病态持续,需综合识别与多学科随访。
核心结论
- 这是首个评估CRRT患儿功能结局的大型多中心研究,出院后持续病态强调综合识别与多学科随访以优化结局。
研究设计与样本
- 纳入出生至25岁因AKI或液体过载接受CRRT的患儿。
- 排除有基础肾病、接受ECMO及非存活者。
- FSS收集于出院(n=527)、出院后6个月(n=387)和12个月(n=344)。
- 主要结局为出院时和6个月FSS;次要结局包括出院和6个月新病态、12个月FSS及肾脏恢复对功能结局的影响。
主要发现
- 527例患者出院时FSS中位数7(6, 90),39%(n=204)FSS较基线变差。
- 出院FSS预测因素:基线FSS OR 1.30(95%CI 1.11-1.52)、体重OR 0.99(95%CI 0.98-0.9997)、合并症OR 1.88(95%CI 1.16-3.04)、机械通气OR 1.72(95%CI 1.04-2.85)、ICU入院时脓毒症OR 1.46(95%CI 1.01-2.21)。
- 6个月FSS显著预测因素:出院FSS OR 2.36(95%CI 1.95-2.84)、合并症OR 1.77(95%CI 1.03-3.06)。
临床怎么用
- 对CRRT存活患儿应评估出院时功能状态并识别新病态。
- 关注基线FSS、合并症、机械通气及脓毒症等出院功能不良预测因素。
- 出院FSS和合并症可预测6个月功能状态,需多学科随访优化结局。
局限性
- 回顾性图表复习设计。
- 排除非存活者及ECMO患者,结论不适用于这些人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND HYPOTHESIS: Mortality rates of children supported with continuous renal replacement therapy (CRRT) have improved, yet morbidity remains high. We aimed to evaluate the functional outcomes of children receiving CRRT using Functional Status Scale (FSS). We hypothesized that children receiving CRRT will have worse FSS compared with their baseline and acquire new morbidity at hospital discharge and 6 and 12 months post-discharge, and that lack of renal recovery will contribute to worsening functional status. METHODS: This is a retrospective chart review from The Worldwide Exploration of Renal Replacement Outcomes Collaborate in Kidney Disease (WE-ROCK), an international multi-center registry. Twenty-eight centers across five countries participated in this analysis. Children from birth to 25 years, on CRRT for acute kidney injury (AKI) or fluid overload, were included. Patients with underlying kidney disease, on extracorporeal membrane oxygenation and non-survivors were excluded. FSS was collected at discharge (n = 527), 6 months (n = 387) and 12 months post-discharge (n = 344). The primary outcome was FSS at discharge and 6 months. Secondary outcomes included: new morbidity at discharge and 6 months; FSS at 12 months; and the impact of renal recovery on functional outcomes. RESULTS: A total of 527 patients had median FSS of 7 (6, 90) at hospital discharge. Thirty-nine percent (n = 204) had worse FSS. Eighteen percent (95/527) acquired a new morbidity at discharge. Predictors of FSS at discharge were baseline FSS {odds ratio (OR) 1.30 [95% confidence interval (CI) 1.11-1.52]}, weight [OR 0.99 (95% CI 0.98-0.9997)], comorbidities [OR 1.88 (95% CI 1.16-3.04)], mechanical ventilation [OR 1.72 (95% CI 1.04-2.85)] and sepsis on intensive care unit admission [OR 1.46 (95% CI 1.01-2.21)]. A total of 387 patients had median FSS score of 6 (6, 8) at 6 months. Ten percent (n = 39/387) acquired new morbidity at 6 months. The significant predictors of FSS at 6 months were FSS at discharge [OR 2.36 (95% CI 1.95-2.84)] and presence of comorbidities [OR 1.77 (95% CI 1.03-3.06)]. CONCLUSION: This is the first large, multi-center study evaluating functional outcomes of children on CRRT. Persistent morbidity following discharge emphasizes the importance of comprehensive identification and multidisciplinary follow-up to optimize patient outcomes.
引用
- Dolan KJ, Gist KM, Basalely A, et al. Functional outcomes in pediatric patients on renal replacement therapy in a worldwide registry. Nephrol Dial Transplant. 2025. PMID: 40258340. doi:10.1093/ndt/gfaf067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。